Morphologic and immunophenotypic characterization of lymphocytosis following BCMAtargeted CAR-T cell therapy in relapsed/refractory multiple myeloma | Synapse
February 2, 2026Open Access
Morphologic and immunophenotypic characterization of lymphocytosis following BCMAtargeted CAR-T cell therapy in relapsed/refractory multiple myeloma
Puntos clave
This research aims to characterize the morphology and immune profile of lymphocytes in response to CAR-T cell therapy in multiple myeloma patients.
Conducted a detailed morphologic assessment of lymphocytes post-treatment
Performed immunophenotyping to identify lymphocyte types
Analyzed changes in lymphocyte characteristics over time post-therapy
Identified significant increases in lymphocyte counts following therapy
Observed distinct immunophenotypic changes indicative of an effective immune response
Characterized specific lymphocyte subpopulations associated with therapy outcomes